本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Heron Therapeutics Inc.

1.93
-0.0700-3.50%
盘后1.940.0100+0.52%19:55 EDT
成交量:106.48万
成交额:210.18万
市值:2.94亿
市盈率:-34.39
高:2.04
开:2.03
低:1.92
收:2.00
数据加载中...
2024/05/31

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/29

重要事件披露

Form 8-K - Current report
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/24

重要事件披露

Form 8-K - Current report
2024/01/12

重要事件披露

Form 8-K - Current report
2023/12/22

重要事件披露

Form 8-K - Current report
2023/12/22

重要事件披露

Form 8-K - Current report
2023/12/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/15

重要事件披露

Form 8-K - Current report
2023/08/30

SEC问询函

Form CORRESP - Correspondence